Classic Cup and Handle for STXS

Company has been plagued by system issues, dilutive financing, short sightedness and questionable management; all of which are great reasons to say the bar is about as low as it can get on this one . About a year ago a small biotech hedge fund took control (DAFNA), kicked out the CEO and installed new blood. DAFNA also brought in a high caliber roster of accredited investors (including Joe Kiani who is the CEO and founder of Masimo ) who have until this point remained very quiet. CEO recently completed a "round the world tour" visiting key accounts and pitched the company at the Piper Jaffray conference.

The chart tells the story; this is a classic cup and handle with a small spike at the end that has since settled down to form another base. We are looking for the stock to take out the $1.10 high on strong volume , which we feel is a near term target in the next 3-4 weeks. The catalyst for this event will be a PR from the company outlining a new strategy to jump start the entire premise of their system as a "robotic vascular solution". Risk reward here looks decent and we are very long.

Final target here is $6.50 which should be in about 2 years.


Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Private Messages Chat Sign Out